Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2018 | 1 |
2020 | 3 |
2021 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Hysteroscopic versus cervical injection for sentinel node detection in endometrial cancer: A multicenter prospective randomised controlled trial from the Multicenter Italian Trials in Ovarian cancer (MITO) study group.
Eur J Cancer. 2020 Nov;140:1-10. doi: 10.1016/j.ejca.2020.08.030. Epub 2020 Oct 5.
Eur J Cancer. 2020.
PMID: 33027722
Clinical Trial.
TARIBO trial: targeted therapy with or without nephrectomy in metastatic renal cell carcinoma: liquid biopsy for biomarkers discovery.
Verzoni E, Ratta R, Grassi P, Salvioni R, Stagni S, Montone R, Fucà G, Cappelletti V, Reduzzi C, De Giorgi U, Procopio G.
Verzoni E, et al. Among authors: montone r.
Tumori. 2018 Oct;104(5):401-405. doi: 10.5301/tj.5000699. Epub 2018 May 9.
Tumori. 2018.
PMID: 29192741
Clinical Trial.
Item in Clipboard
Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression.
Cappelletti V, Verzoni E, Ratta R, Vismara M, Silvestri M, Montone R, Miodini P, Reduzzi C, Claps M, Sepe P, Daidone MG, Procopio G.
Cappelletti V, et al. Among authors: montone r.
Int J Mol Sci. 2020 Feb 21;21(4):1475. doi: 10.3390/ijms21041475.
Int J Mol Sci. 2020.
PMID: 32098246
Free PMC article.
Clinical Trial.
Item in Clipboard
Corrigendum to "Hysteroscopic versus cervical injection for sentinel node detection in endometrial cancer: A multicenter prospective randomised controlled trial from the Multicenter Italian Trials in Ovarian cancer (MITO) study group" [European Journal of Cancer. Volume 140, November 2020, Pages 1-10].
Ditto A, Casarin J, Pinelli C, Perrone AM, Scollo P, Martinelli F, Bogani G, Leone Roberti Maggiore U, Signorelli M, Chiappa V, Giorda G, Scibilia G, De Iaco P, Evangelista M, Ghezzi F, Paolini B, Lo Vullo S, Mariani L, Montone R, Raspagliesi F.
Ditto A, et al. Among authors: montone r.
Eur J Cancer. 2021 Feb;144:399. doi: 10.1016/j.ejca.2020.11.018. Epub 2020 Dec 17.
Eur J Cancer. 2021.
PMID: 33342624
No abstract available.
Item in Clipboard
TOKIO rationale and protocol: a phase II study to evaluate the activity and safety of third-line tyrosine kinase inhibitor after 2 tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma.
Verzoni E, Grassi P, Montone R, Galli G, Necchi A, Procopio G.
Verzoni E, et al. Among authors: montone r.
Tumori. 2015 Nov-Dec;101(6):701-3. doi: 10.5301/tj.5000335. Epub 2015 Jun 20.
Tumori. 2015.
PMID: 26108242
Clinical Trial.
Item in Clipboard
Cite
Cite